Advertisement
Screener

CONMED CORPORATION (CNMD) Graph

CNMD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $343.49M; Cost of revenue $146.03M; Research and development $15.50M; Selling, general and administrative $145.55M.
  • 2025-12-31: Revenue $373.20M*; Cost of revenue $154.91M*; Research and development $14.90M*; Selling, general and administrative $166.76M*.
  • 2025-09-30: Revenue $337.93M; Cost of revenue $171.81M; Research and development $13.90M; Selling, general and administrative $140.34M.
  • 2025-06-30: Revenue $342.35M; Cost of revenue $154.03M; Research and development $14.14M; Selling, general and administrative $136.02M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CNMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.General Surgery$191.17MOrthopedic Surgery$152.32MRevenue$343.49MCost of revenue$146.03MGross profit$197.46MOperating expenses$161.05MOperating income$36.40MOther income, net$2.82MResearch & development$15.50MSelling, general& administrative$145.55MPre-tax income$31.35MIncome tax$8.28MNet income$23.07M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CNMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Asia Pacific$57.16MEMEA$76.15MAmericasexcludingtheUnited States$34.80MUS$175.38MRevenue$343.49MCost of revenue$146.03MGross profit$197.46MOperating expenses$161.05MOperating income$36.40MOther income, net$2.82MResearch & development$15.50MSelling, general& administrative$145.55MPre-tax income$31.35MIncome tax$8.28MNet income$23.07M

Timing Of Transfer Of Good Or Service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CNMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Transferred AtPoint In Time$328.06MTransferred Over Time$15.43MRevenue$343.49MCost of revenue$146.03MGross profit$197.46MOperating expenses$161.05MOperating income$36.40MOther income, net$2.82MResearch & development$15.50MSelling, general& administrative$145.55MPre-tax income$31.35MIncome tax$8.28MNet income$23.07M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$343.49M$146.03M$15.50M$145.55M$161.05M$8.28M$23.07M
2025-12-31$373.20M*$154.91M*$14.90M*$166.76M*$181.66M*$12.51M*$16.78M*
2025-09-30$337.93M$171.81M$13.90M$140.34M$154.24M$1.41M$2.86M
2025-06-30$342.35M$154.03M$14.14M$136.02M$150.16M$8.50M$21.42M
2025-03-31$321.26M$143.50M$12.95M$148.85M$161.79M$1.64M$6.04M
2024-09-30$316.70M$137.71M$13.56M$99.73M$113.29M$7.47M$48.98M
2024-06-30$332.10M$148.37M$14.10M$122.52M$136.62M$7.54M$29.98M
2024-03-31$312.27M$140.31M$13.59M$123.36M$136.95M$5.71M$19.71M
2023-09-30$304.58M$136.52M$12.46M$125.30M$137.76M$4.44M$15.84M
2023-06-30$317.65M$146.96M$13.57M$129.70M$143.27M$3.69M$13.73M
2023-03-31$295.47M$140.15M$12.54M$130.08M$142.62M$625.00K$1.82M
2022-09-30$275.09M$123.47M$12.77M$114.60M$127.37M-$30.44M$46.15M
2022-06-30$277.19M$125.41M$11.49M$115.83M$127.32M$74.81M-$168.29M
2022-03-31$242.33M$106.34M$10.67M$102.88M$113.55M$2.47M$14.97M
2021-09-30$248.83M$106.52M$10.86M$104.74M$115.59M$2.49M$14.95M
2021-06-30$255.16M$113.74M$11.32M$104.40M$115.72M$3.00M$13.29M
2021-03-31$232.68M$104.23M$10.03M$98.34M$108.37M-$129.00K$9.86M
2020-12-31$252.83M(m)(m)(m)(m)(m)$24.14M
2020-09-30$237.84M$104.14M$9.94M$94.38M$104.32M$10.50M$6.85M
2020-06-30$157.78M$85.86M$8.70M$84.47M$93.17M-$5.34M-$27.40M
2020-03-31$214.01M$94.85M$10.12M$95.87M$105.99M-$2.44M$5.93M
2019-12-31$264.87M(m)(m)(m)(m)(m)$14.93M
2019-09-30$233.59M$103.48M$10.98M$98.19M$109.17M$2.47M$6.97M
2019-06-30$238.26M$107.07M$11.81M$100.73M$112.53M$803.00K$5.70M
2019-03-31$218.38M$96.94M$10.57M$99.23M$109.80M-$2.98M$1.02M
2018-12-31$242.44M(m)(m)(m)(m)(m)$15.65M
2018-09-30$202.31M$91.68M$14.12M$84.98M$99.11M$483.00K$5.83M
2018-06-30$212.82M$96.55M$9.98M$89.60M$99.59M$2.87M$8.72M
2018-03-31$202.06M$92.51M$7.71M$84.57M$92.28M$1.80M$10.66M
2017-12-31$222.56M(m)(m)(m)(m)(m)$46.70M
2017-09-30$190.12M$87.57M$8.27M$80.81M$89.08M$1.47M$7.20M
2017-06-30$197.15M$92.50M$8.04M$83.83M$91.87M$2.25M$6.14M
2017-03-31$186.57M$86.68M$7.62M$94.76M$102.38M-$2.07M-$4.54M
2016-12-31$204.09M(m)(m)(m)(m)(m)$6.71M
2016-09-30$184.79M$83.58M$8.35M$79.01M$87.36M$2.65M$7.34M
2016-06-30$193.43M$91.01M$8.01M$86.73M$94.74M$1.04M$2.88M
2016-03-31$181.20M$83.46M$8.26M$85.94M$94.20M-$968.00K-$2.27M
2015-12-31$191.02M(m)(m)(m)(m)(m)$7.85M
2015-09-30$169.18M$75.64M$6.65M$72.06M$78.71M$4.46M$8.87M
2015-06-30$181.03M$87.53M$7.50M$73.58M$81.08M$3.47M$7.46M
2015-03-31$177.94M$85.66M$6.54M$74.79M$81.33M$3.18M$6.31M
2014-12-31$195.00M(m)(m)(m)(m)(m)$11.34M
2014-09-30$174.96M$78.55M$6.91M$87.06M$93.97M-$1.06M$1.97M
2014-06-30$188.15M$87.12M$6.85M$78.23M$85.09M$4.11M$10.26M
2014-03-31$181.94M$79.36M$6.91M$78.36M$85.27M$7.22M$8.63M
2013-12-31$203.44M(m)(m)(m)(m)(m)$10.23M
2013-09-30$179.25M$83.83M$7.11M$73.48M$86.62M$1.74M$5.69M
2013-06-30$192.99M$90.08M$6.59M$77.17M$87.26M$4.74M$9.53M
2013-03-31$187.01M$84.33M$5.69M$77.72M$86.81M$3.75M$10.49M
2012-12-31$201.24M(m)(m)(m)(m)(m)$10.90M
2012-09-30$181.88M$83.97M$7.08M$74.06M$83.80M$3.45M$9.32M
2012-06-30$189.69M$89.96M$7.19M$73.71M$82.67M$5.21M$10.30M
2012-03-31$194.32M$93.41M$7.09M$74.81M$83.89M$5.62M$9.97M
2011-12-31$185.58M(m)(m)(m)(m)(m)-$25.13M
2011-09-30$172.81M$81.50M$7.02M$68.35M$75.37M$4.93M$8.21M
2011-06-30$183.24M$91.78M$6.80M$67.86M$74.76M$5.20M$8.68M
2011-03-31$183.45M$87.73M$7.68M$70.08M$78.45M$5.37M$8.99M
2010-12-31$184.08M(m)(m)(m)(m)(m)$6.96M
2010-09-30$172.19M$83.21M$7.40M$66.09M$73.78M$3.64M$8.76M
2010-06-30$181.09M$87.40M$6.44M$71.49M$78.91M$4.57M$7.31M
2010-03-30$176.37M(m)(m)(m)(m)(m)$7.32M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$660.53M$279.63M$31.83M$287.25M$319.08M$12.80M$36.90M
2025-06-30$663.60M$297.53M$27.08M$284.87M$311.95M$10.13M$27.46M
2024-06-30$644.37M$288.68M$27.69M$245.88M$273.57M$13.25M$49.69M
2023-06-30$613.12M$287.11M$26.11M$259.78M$285.89M$4.31M$15.55M
2022-06-30$519.52M$231.75M$22.16M$218.70M$240.87M$77.28M-$153.32M
2021-06-30$487.84M$217.96M$21.34M$202.74M$224.08M$2.87M$23.15M
2020-06-30$371.80M$180.71M$18.82M$180.34M$199.16M-$7.77M-$21.47M
2019-06-30$456.64M$204.01M$22.38M$199.95M$222.33M-$2.17M$6.72M
2018-06-30$414.88M$189.06M$17.70M$174.17M$191.87M$4.67M$19.38M
2017-06-30$383.72M$179.18M$15.66M$178.59M$194.25M$177.00K$1.59M
2016-06-30$374.63M$174.47M$16.27M$172.67M$188.94M$75.00K$619.00K
2015-06-30$358.97M$173.19M$14.04M$148.37M$162.41M$6.65M$13.77M
2014-06-30$370.09M$166.48M$13.76M$156.60M$170.36M$11.34M$18.88M
2013-06-30$380.01M$174.41M$12.29M$154.90M$174.08M$8.48M$20.02M
2012-06-30$384.01M$183.37M$14.29M$148.51M$166.56M$10.83M$20.26M
2011-06-30$366.69M$179.51M$14.48M$137.94M$153.21M$10.57M$17.68M
2010-06-30$357.45M$171.97M$14.12M$142.05M$157.14M$8.01M(m)

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$1.00B$469.34M$40.98M$425.21M$466.19M$11.55M$30.32M
2024-09-30$961.07M$426.38M$41.25M$345.61M$386.86M$20.72M$98.67M
2023-09-30$917.70M$423.63M$38.57M$385.08M$423.65M$8.76M$31.39M
2022-09-30$794.61M$355.22M$34.93M$333.30M$368.23M$46.84M-$107.17M
2021-09-30$736.66M$324.49M$32.20M$307.48M$339.68M$5.36M$38.10M
2020-09-30$609.63M$284.85M$28.76M$274.72M$303.48M$2.73M-$14.62M
2019-09-30$690.23M$307.49M$33.37M$298.14M$331.51M$299.00K$13.69M
2018-09-30$617.19M$280.74M$31.82M$259.16M$290.97M$5.16M$25.20M
2017-09-30$573.84M$266.75M$23.93M$259.40M$283.32M$1.65M$8.79M
2016-09-30$559.43M$258.06M$24.62M$251.68M$276.30M$2.72M$7.96M
2015-09-30$528.15M$248.82M$20.70M$220.42M$241.12M$11.11M$22.65M
2014-09-30$545.05M$245.03M$20.67M$243.65M$264.33M$10.27M$20.85M
2013-09-30$559.26M$258.24M$19.39M$228.38M$260.69M$10.22M$25.71M
2012-09-30$565.90M$267.34M$21.36M$222.58M$250.36M$14.28M$29.58M
2011-09-30$539.50M$261.02M$21.50M$206.29M$228.58M$15.49M$25.89M
2010-09-30$529.65M$255.19M$21.52M$208.14M$230.92M$11.64M(m)

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$1.37B$624.25M$55.88M$591.97M$647.85M$24.06M$47.10M
2024-12-31$1.31B$573.98M$54.43M$478.28M$532.71M$30.61M$132.40M
2023-12-31$1.24B$568.50M$52.60M$503.04M$555.64M$16.37M$64.50M
2022-12-31$1.05B$474.23M$47.15M$454.04M$501.19M$9.72M-$80.60M
2021-12-31$1.01B$442.60M$43.56M$414.75M$458.32M$10.56M$62.50M
2020-12-31$862.46M$402.16M$40.47M$373.82M$414.29M-$7.91M$9.52M
2019-12-31$955.10M$430.38M$45.46M$400.14M$445.60M$2.60M$28.62M
2018-12-31$859.63M$390.52M$42.19M$355.62M$397.81M$9.80M$40.85M
2017-12-31$796.39M$365.35M$32.31M$351.80M$384.11M-$26.75M$55.49M
2016-12-31$763.52M$355.19M$32.25M$338.40M$370.65M$4.71M$14.66M
2015-12-31$719.17M$337.47M$27.44M$303.09M$330.53M$14.65M$30.50M
2014-12-31$740.05M$336.00M$27.78M$323.49M$351.27M$14.48M$32.19M
2013-12-31$762.70M$350.29M$25.83M$330.08M$355.91M$14.69M$35.94M
2012-12-31$767.14M$361.30M$28.21M$302.47M$340.63M$19.00M$40.48M
2011-12-31$725.08M$350.14M$28.65M$276.62M$366.66M-$3.06M$752.00K
2010-12-31$713.72M$348.34M$29.65M$276.46M$308.29M$15.31M$30.35M
2009-12-31$694.74M$357.41M$31.84M$266.31M$309.06M$6.02M$12.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ceribell, Inc. (CBLL)United States$0.916B-11.27
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
Axogen, Inc. (AXGN)United States$2.329B-73.83
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B